Growth Metrics

Pacific Biosciences Of California (PACB) Cash & Equivalents Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -3.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.82%
Dec 31, 2025 15.06%
Sep 30, 2025 -27.59%
Jun 30, 2025 -44.94%
Mar 31, 2025 -23.67%
Dec 31, 2024 -69.22%
Sep 30, 2024 -79.78%
Jun 30, 2024 -52.45%
Mar 31, 2024 -78.34%
Dec 31, 2023 -44.66%
Sep 30, 2023 26.68%
Jun 30, 2023 -32.58%
Mar 31, 2023 -17.44%
Dec 31, 2022 -29.44%
Jun 30, 2022 -32.48%
Mar 31, 2022 -54.04%
Dec 31, 2021 464.54%
Jun 30, 2021 960.85%
Mar 31, 2021 1,254.01%
Dec 31, 2020 175.46%
Sep 30, 2020 108.64%
Jun 30, 2020 42.77%
Mar 31, 2020 80.24%
Dec 31, 2019 57.22%
Sep 30, 2019 -13.08%
Jun 30, 2019 31.66%
Mar 31, 2019 50.07%
Dec 31, 2018 14.16%
Sep 30, 2018 46.79%
Jun 30, 2018 -36.79%
Mar 31, 2018 -12.16%
Dec 31, 2017 -1.54%
Sep 30, 2017 13.76%
Jun 30, 2017 47.22%
Mar 31, 2017 44.33%
Dec 31, 2016 -50.15%
Sep 30, 2016 -16.22%
Jun 30, 2016 -4.44%
Mar 31, 2016 -33.67%
Dec 31, 2015 -7.74%
Sep 30, 2015 -23.17%
Jun 30, 2015 -8.05%
Mar 31, 2015 -26.64%
Dec 31, 2014 38.26%
Sep 30, 2014 -45.33%
Jun 30, 2014 -30.94%
Mar 31, 2014 -22.20%
Dec 31, 2013 -43.36%
Sep 30, 2013 98.93%
Jun 30, 2013 21.44%
Mar 31, 2013 -5.73%
Dec 31, 2012 -20.94%
Sep 30, 2012 -43.46%
Jun 30, 2012 -38.32%
Mar 31, 2012 -33.51%
Dec 31, 2011 -60.13%
Sep 30, 2011 -8.19%
Jun 30, 2011 -39.53%